Celecoxib in Preventing the Damaging Effects of Sunburn in Healthy Volunteers

NCT02099136 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

45

Enrollment

NIH

Sponsor class

Conditions

No Evidence of Disease

Interventions

PROCEDURE: UV Light Therapy
OTHER: Placebo
DRUG: Celecoxib
PROCEDURE: Biopsy
OTHER: Imaging Biomarker Analysis

Sponsor

National Cancer Institute (NCI)